Copy
Analyzing VC-backed email apps. The Best of June.

Like The Kleiner Perkins teardown on Facebook share on Twitter
Debbie Downer
 
Hi,
 
Sam Altman, the new czar of Y Combinator, had a good post about valuations recently. In it, he talked about the advantages of having a Board to force accountability. Since we don't have outside investors, we've found two powerful forces of accountability in the form of our customers and the team. 

Here's our perspective on accountability to them.

What do you think about our philosophy on accountability?  Leave a comment on the post or drop me a note if you violently agree or disagree.

In unrelated news, I presented at the PreMoney conference last Friday in San Francisco. Before my talk, I warned everyone that I'd be the most depressing talk of the day. And I nailed it.

Specifically, I talked about assessing the effectiveness of micro VCs, angels and corporate VCs using data. 

For those who couldn't attend, the full presentation is here. Although the presentation is pretty straightforward, I've also written up slide by slide notes to accompany the presentation in case. Those are here.

Have a great day.

Anand
@asanwal

P.S.  The Facebook Like and Tweet buttons now allow you to share the whole campaign in case you just love the entire newsletter.
Like The Kleiner Perkins teardown on Facebook share on Twitter

 

The R.I.P. report - Startup death trends

For most startups whose tech or talent is not compelling enough to catch the eye of the Googles, Facebooks, or Yahoos of the world, the cold hard reality is death. See the full breakdown of CB Insights startup mortality data.
Tweet this

You've got mail - Analyzing App Store data for VC-backed email apps

As email consumption increasingly turns to mobile devices, a host of email apps have emerged to make the mobile email process more effortless and efficient. See how VC-backed email apps including Acompli and Boxer have trended in the App Store.
Tweet this

Corporate VCs put $2.2B into healthcare over past four quarters

Norvartis, Johnson & Johnson, and GlaxoSmithKline's SR One were the most active corporate VCs in the healthcare space which has garnered billions from corporate investors. See the data on investment trends and top corporate investors in healthcare.
Tweet this

Kleiner Perkins Caufield & Byers teardown

The Silicon Valley legend hasn't raised a new fund in 2 years and is investing more at the mid-stage. We dive into the data to understand KPCB's financing strategy, investment thesis, key people, exit history, investment syndicates and more.
Tweet this

7 things to read this week

A selection of 7 articles that the CB Insights team found entertaining, engaging or thought-provoking.

Everything we know about Facebook's emotional state study. The Atlantic breaks it down.

Goodbye, for now, San Francisco. Nick Bilton and Mike Isaac of the New York Times reflect on time spent in Silicon Valley.

Moneyball questions, moneyball answers. An excerpt from Jonathan Tjarks' "The Pattern of Basketball and the 2014 NBA Draft"

The World Cup of gaming. 40,000 to 50,000 people are expected at the League of Legends game championship in Seoul.

The IPO is dying. A16Z's Marc Andreessen explains why.

The second seed round. Is it crazy to do two seed rounds? The short answer is no, says Nuzzel's Jonathan Abrams.(featuring a shoutout to CB Insights data)

The millennial definition of success. "This generation overwhelmingly associates success with control over who they work with, and what they work on," writes Wealthfront's Adam Nash.

Our Last Two Newsletters

In case you missed them:

Copyright © 2014 CB Information Services, All rights reserved.